The Breast Cancer Susceptibility-related Polymorphisms at the TOX3/LOC643714 Locus Associated with Lung Cancer Risk in a Han Chinese Population

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Aug 4

PMID 27486757

Citations 4

Authors

Chaowen Jiang

Shilong Yu

Pin Qian

Ruiling Guo

Ruijie Zhang

Zhi Ao

Qi Li

Guoming Wu

Yan Chen

Jin Li

Changzheng Wang

Wei Yao

Jiancheng Xu

Guisheng Qian

Fuyun Ji

Affiliations

Soon will be listed here.

Abstract

It has been well established that besides environmental factors, genetic factors are also associated with lung cancer risk. However, to date, the prior identified genetic variants and loci only explain a small fraction of the familial risk of lung cancer. Hence it is vital to investigate the remaining missing heritability to understand the development and process of lung cancer. In the study, to test our hypothesis that the previously identified breast cancer risk-associated genetic polymorphisms at the TOX3/LOC643714 locus might contribute to lung cancer risk, 16 SNPs at the TOX3/LOC643714 locus were evaluated in a Han Chinese population based on a case-control study. Pearson's chi-square test or Fisher's exact test revealed that rs9933638, rs12443621, and rs3104746 were significantly associated with lung cancer risk (P < 0.001, P < 0.001, and P = 0.005, respectively). Logistic regression analyses displayed that lung cancer risk of individuals with rs9933638(GG+GA) were 1.89 times higher than that of rs9933638AA carriers (OR = 1.893, 95% CI = 1.308-2.741, P = 0.001). Similar findings were manifested for rs12443621 (OR = 1.824, 95% CI = 1.272-2.616, P = 0.001, rs12443621(GG+GA) carriers vs. rs12443621AA carriers) and rs3104746 (OR = 1.665, 95% CI = 1.243-2.230, P = 0.001, rs3104746TT carriers vs. rs3104746(TA+AA) carriers). The study discovered for the first time that three SNPs (rs9933638, rs12443621, and rs3104746) at the TOX3/LOC643714 locus contributed to lung cancer risk, providing new evidences that lung cancer and breast cancer are linked at the molecular and genetic level to a certain extent.

Citing Articles

Understanding genetic variations associated with familial breast cancer.

Pal M, Das D, Pandey M World J Surg Oncol. 2024; 22(1):271.

PMID: 39390525 PMC: 11465949. DOI: 10.1186/s12957-024-03553-9.

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.

Hao J, Huang J, Hua C, Zuo Y, Yu W, Wu X PLoS Biol. 2023; 21(9):e3002256.

PMID: 37708089 PMC: 10501593. DOI: 10.1371/journal.pbio.3002256.

Risk Association of and Gene Polymorphisms with Sporadic Breast Cancer in Mexican Women.

Solis-Coronado O, Villarreal-Vela M, Rodriguez-Gutierrez H, Gonzalez-Guerrero J, Cerda-Flores R, Alcorta-Nunez F Curr Oncol. 2022; 29(2):1008-1017.

PMID: 35200585 PMC: 8870835. DOI: 10.3390/curroncol29020086.

Association between the TOX3 rs3803662 C>T polymorphism and recurrent miscarriage in a southern Chinese population.

Huang W, Zhou H, Li Q, Pi L, Xu Y, Fu L J Clin Lab Anal. 2019; 33(9):e22992.

PMID: 31454102 PMC: 6868414. DOI: 10.1002/jcla.22992.

References

Huo D, Zheng Y, Ogundiran T, Adebamowo C, Nathanson K, Domchek S . Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis. 2012; 33(4):835-40. PMC: 3324445. DOI: 10.1093/carcin/bgs093. View

Bayraktar S, Thompson P, Yoo S, Do K, Sahin A, Arun B . The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Oncologist. 2013; 18(5):493-500. PMC: 3662839. DOI: 10.1634/theoncologist.2012-0419. View

Easton D, Pooley K, Dunning A, Pharoah P, Thompson D, Ballinger D . Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007; 447(7148):1087-93. PMC: 2714974. DOI: 10.1038/nature05887. View

Zheng W, Wen W, Gao Y, Shyr Y, Zheng Y, Long J . Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010; 102(13):972-81. PMC: 2897876. DOI: 10.1093/jnci/djq170. View

Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G . Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer. 2009; 46(4):758-64. DOI: 10.1016/j.ejca.2009.12.010. View

Chen M, Wu X, Shen W, Wei M, Li C, Cai B . Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects. Breast Cancer Res Treat. 2010; 126(1):177-83. DOI: 10.1007/s10549-010-1114-6. View

Stevens K, Vachon C, Lee A, Slager S, Lesnick T, Olswold C . Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011; 71(19):6240-9. PMC: 3327299. DOI: 10.1158/0008-5472.CAN-11-1266. View

Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte E, Trenkwalder C . Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet. 2011; 7(7):e1002171. PMC: 3136436. DOI: 10.1371/journal.pgen.1002171. View

Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S . The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis. 2011; 26(3):437-46. DOI: 10.1093/mutage/ger002. View

10.

Ruiz-Narvaez E, Rosenberg L, Cozier Y, Cupples L, Adams-Campbell L, Palmer J . Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev. 2010; 19(5):1320-7. PMC: 2866101. DOI: 10.1158/1055-9965.EPI-09-1250. View

11.

Antoniou A, Spurdle A, Sinilnikova O, Healey S, Pooley K, Schmutzler R . Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008; 82(4):937-48. PMC: 2427217. DOI: 10.1016/j.ajhg.2008.02.008. View

12.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K . Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007; 631(2):101-10. DOI: 10.1016/j.mrgentox.2007.03.010. View

13.

Lin C, Chen M, Wu V, Li W, Sy H, Wu S . Association of candidate genetic variants with restless legs syndrome in end stage renal disease: a multicenter case-control study in Taiwan. Eur J Neurol. 2014; 21(3):492-8. DOI: 10.1111/ene.12337. View

14.

Gabriel S, Schaffner S, Nguyen H, Moore J, Roy J, Blumenstiel B . The structure of haplotype blocks in the human genome. Science. 2002; 296(5576):2225-9. DOI: 10.1126/science.1069424. View

15.

Zheng S, Qian P, Li F, Qian G, Wang C, Wu G . Association of mitochondrial DNA variations with lung cancer risk in a Han Chinese population from southwestern China. PLoS One. 2012; 7(2):e31322. PMC: 3283641. DOI: 10.1371/journal.pone.0031322. View

16.

Stacey S, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson S . Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007; 39(7):865-9. DOI: 10.1038/ng2064. View

17.

Zhang L, Long X . Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls. Sci Rep. 2015; 5:12773. PMC: 4523945. DOI: 10.1038/srep12773. View

18.

Cowper-Sal Lari R, Zhang X, Wright J, Bailey S, Cole M, Eeckhoute J . Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet. 2012; 44(11):1191-8. PMC: 3483423. DOI: 10.1038/ng.2416. View

19.

Orr N, Cooke R, Jones M, Fletcher O, Dudbridge F, Chilcott-Burns S . Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men. PLoS Genet. 2011; 7(9):e1002290. PMC: 3174231. DOI: 10.1371/journal.pgen.1002290. View

20.

Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L . Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population. Breast Cancer Res Treat. 2010; 124(1):237-41. DOI: 10.1007/s10549-010-0809-z. View